Literature DB >> 19550136

Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.

Adit Ben-Baruch1.   

Abstract

The metastatic spread of tumors is a well-coordinated process in which different types of cancers tend to form metastases in defined organs. The formation of site-specific metastases requires full compatibility between the intrinsic properties of the tumor cells and the tumor microenvironment. It was recently found that chemokines which are expressed in specific loci promote the adhesion, migration and invasion of tumor cells that express the corresponding receptor(s). Of the different members of the family, the CXCL12 chemokine and its cognate CXCR4 receptor are the prototypes of this process, although other members of the family (e.g. CCR7 and CCR10) also play a role in determination of the metastatic spread. This commentary addresses the fundamental roles of chemokines and their receptors in site-specific metastasis, with emphasis on CXCL12-CXCR4. The article also describes some of the efforts that were performed thus far in order to identify the intracellular components involved in this process. The focus is put on the roles played by proteins that regulate adhesion and migration of tumor cells in response to CXCL12, including mainly focal adhesion kinase (FAK), Pyk2/RAFTK and members of the Rho family of GTPases (RhoA, Rac, Cdc42). This is followed by discussion of open questions that need to be addressed in future research, and of the potential therapeutic implications of the findings that are available to date in this field.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550136      PMCID: PMC2802740          DOI: 10.4161/cam.3.4.9211

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  30 in total

Review 1.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.

Authors:  Antal Rot; Ulrich H von Andrian
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 2.  Role of tumor cell adhesion and migration in organ-specific metastasis formation.

Authors:  P Gassmann; A Enns; J Haier
Journal:  Onkologie       Date:  2004-12

3.  The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.

Authors:  Denise Lepley; Ji-Hye Paik; Timothy Hla; Fernando Ferrer
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

Review 4.  The significance of cancer cell expression of the chemokine receptor CXCR4.

Authors:  Fran Balkwill
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

5.  Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.

Authors:  Rubén A Bartolomé; Beatriz G Gálvez; Natividad Longo; Françoise Baleux; Goos N P Van Muijen; Paloma Sánchez-Mateos; Alicia G Arroyo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

Review 6.  The organ microenvironment and cancer metastasis.

Authors:  Isaiah J Fidler
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

7.  Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.

Authors:  Byeong-Chel Lee; Tae-Hee Lee; Shalom Avraham; Hava Karsenty Avraham
Journal:  Mol Cancer Res       Date:  2004-06       Impact factor: 5.852

8.  Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.

Authors:  Aaron Zefrin Fernandis; Anil Prasad; Hamid Band; Roland Klösel; Ramesh Kumar Ganju
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

9.  Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells.

Authors:  Anil Prasad; Aaron Z Fernandis; Yi Rao; Ramesh K Ganju
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

10.  New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.

Authors:  C Denoyelle; L Hong; J-P Vannier; J Soria; C Soria
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

View more
  24 in total

1.  Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.

Authors:  Miodrag Dragoj; Jasna Bankovic; Evangelia Sereti; Sofija Jovanovic Stojanov; Konstantinos Dimas; Milica Pesic; Tijana Stankovic
Journal:  Invest New Drugs       Date:  2017-07-22       Impact factor: 3.850

2.  Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome.

Authors:  Kevin B Walters; Julie M Green; Jill C Surfus; Sa Kan Yoo; Anna Huttenlocher
Journal:  Blood       Date:  2010-06-30       Impact factor: 22.113

3.  Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.

Authors:  Yangyang Hu; Lin Lu; Yang Xia; Xin Chen; Alfred E Chang; Robert E Hollingsworth; Elaine Hurt; John Owen; Jeffrey S Moyer; Mark E P Prince; Fu Dai; Yangyi Bao; Yi Wang; Joel Whitfield; Jian-Chuan Xia; Shiang Huang; Max S Wicha; Qiao Li
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

Review 4.  CXC chemokines in cancer angiogenesis and metastases.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

5.  Antiproliferative and hepatoprotective activity of metabolites from Corynebacterium xerosis against Ehrlich Ascites Carcinoma cells.

Authors:  Farhadul Islam; Soby Ghosh; Jahan Ara Khanam
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 6.  CXCR4: a virus's best friend?

Authors:  Kathleen L Arnolds; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2014-05-02       Impact factor: 3.342

7.  Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line.

Authors:  Xiao-Ping Chen; Lin-Lin Qian; Hong Jiang; Jiang-Hua Chen
Journal:  Int J Clin Oncol       Date:  2011-04-01       Impact factor: 3.402

8.  The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.

Authors:  Liping Qiu; Yuanyuan Xu; Hui Xu; Biyun Yu
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

9.  A microfluidic model for organ-specific extravasation of circulating tumor cells.

Authors:  R Riahi; Y L Yang; H Kim; L Jiang; P K Wong; Y Zohar
Journal:  Biomicrofluidics       Date:  2014-03-11       Impact factor: 2.800

10.  β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma.

Authors:  Ian C Clift; Adebowale O Bamidele; Christie Rodriguez-Ramirez; Kimberly N Kremer; Karen E Hedin
Journal:  Mol Pharmacol       Date:  2014-01-22       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.